Brianne Harper, PA
Medical · Grand Junction, CONPI 1700430261
Payments from drug & device makers
Across 239 payments — averaging $20.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$864
- Sun Pharmaceutical Industries Inc.$541
- Johnson & Johnson$474
- Sanofi$422
- Lilly USA, LLC$418
- Novartis$415
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,32587%
- Education$66113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $864 |
| Sun Pharmaceutical Industries Inc. | 13 | $541 |
| Johnson & Johnson | 20 | $474 |
| Sanofi | 19 | $422 |
| Lilly USA, LLC | 21 | $418 |
| Novartis | 25 | $415 |
| Regeneron Healthcare Solutions, Inc. | 11 | $368 |
| Amgen | 14 | $291 |
| UCB, Inc. | 8 | $177 |
| Incyte Corporation | 8 | $152 |
| Biofrontera Inc. | 9 | $148 |
| LEO Pharma Inc. | 5 | $110 |
| Pfizer | 5 | $101 |
| E.r. Squibb & Sons, L.L.C. | 4 | $98 |
| Boehringer Ingelheim | 3 | $64 |
| Galderma Laboratories, L.p. | 4 | $63 |
| Sandoz | 2 | $56 |
| Arcutis Biotherapeutics, Inc. | 3 | $50 |
| Organon | 3 | $45 |
| Krystal Biotech Inc | 1 | $30 |
| Biocon Biologics Inc | 1 | $25 |
| Organogenesis Inc. | 1 | $23 |
| Botanix SB Inc | 1 | $18 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $15 |
How this compares
$4,986 in reported general payments places this provider in the 85th percentile of 766 medical providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 127 | $496,388 |
| Skyrizi PenRisankizumab-Rzaa | 14 | $275,406 |
| Humira(Cf) PenAdalimumab | 15 | $113,736 |
| Clobetasol Propionate | 108 | $5,389 |
| Mometasone Furoate | 131 | $3,037 |
| Fluorouracil | 36 | $2,766 |
| Triamcinolone Acetonide | 310 | $2,398 |
| Ketoconazole | 136 | $2,344 |
| Tacrolimus | 16 | $2,235 |
| Doxycycline Hyclate | 177 | $1,504 |
| Imiquimod | 40 | $1,238 |
| Clindamycin Phosphate | 36 | $1,135 |
| Spironolactone | 64 | $937 |
| Mupirocin | 125 | $928 |
| Minocycline Hcl | 20 | $670 |
Paid to pharmacies, not to this prescriber.
Other medical in Grand Junction
- Christen KutzColorado Springs$2.4M
- Amanda MixonFort Collins$342K
- Kristin RyggColorado Springs$255K
- Jordan MastDenver$247K
- John NovakAurora$173K
- Michelle BarnettColorado Springs$138K
- Michael JacobsonFort Collins$131K
- Lindsey TunstallAurora$87K
- Jennifer NafzigerHighlands Ranch$80K
- Daniel TaylorDenver$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.